Laddar...
Saxagliptin for type 2 diabetes
Saxagliptin (Onglyza™) is a potent, selective, once-daily dipeptidyl peptidase-4 (DPP-4) inhibitor indicated for improving glycemic control in patients with type 2 diabetes (T2D). By blocking DPP-4, saxagliptin increases and prolongs the effects of incretins, a group of peptide hormones released by...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3047974/ https://ncbi.nlm.nih.gov/pubmed/21437102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSOTT.S12241 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|